As the baby boomers age, science is focusing in on longevity.
How we age and how to stop aging are hot topics, and researchers are looking for answers.
According to a recent article in the journal Nature, the medication Rapamycin was shown to significantly increase the lifespan of mice. Rapamycin is an FDA approved medication for patients with organ transplants to help prevent their body from rejecting the transplanted organ.
Rapamycin modifies the way in which the immune system functions. In some ways, it inhibits the immune system and in other ways in helps the immune system.
Study authors report that Rapamycin inhibits a specific protein called mTOR which is involved in cellular longevity, although the exact mechanism for the increase in cellular lifespan is not known.
The study showed that mice who were given Rapamycin had an increase in average lifespan- up to 10 percent longer.
This is a significant increase and a big advancement in the search for longevity.
Researchers now need to look for answers as to why this occurred and how to apply them to human subjects.
Cristopher Geiler, M.D.
Reference
Nature 8 July 2009
Comment by Pill may extend lifespan
07-11-2009
[...] post: Pill may extend lifespan AKPC_IDS += "35910,";Popularity: unranked [?] Comments [0]Digg [...]
Comment by Pill may extend lifespan
07-11-2009
[...] rest is here: Pill may extend lifespan AKPC_IDS += "35908,";Popularity: unranked [?] Comments [0]Digg [...]
Comment by Pill may extend lifespan
07-11-2009
[...] the original: Pill may extend lifespan AKPC_IDS += "35909,";Popularity: unranked [?] Comments [0]Digg [...]
Comment by Pill may extend lifespan
07-11-2009
[...] post: Pill may extend lifespan AKPC_IDS += "35907,";Popularity: unranked [?] Comments [0]Digg [...]
No heart benefit seen with fibrates in diabetics
ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke... [via Reuters]Abbott's heart valve device proves safe, effective
ATLANTA (Reuters) - An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and... [via Reuters]Novartis drugs fail to help high-risk patients
ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients... [via Reuters]U.S. court rules again against vaccine-autism claims
WASHINGTON (Reuters) - Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court... [via Reuters]Women on the pill live longer: study
LONDON (Reuters) - One of the world's largest studies of the contraceptive pill has found that women who have taken it can expect longer lives and... [via Reuters]